---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285084724.md"
description: "22nd Century Group shares are trading lower after the company annoucned it filed a prospectus to sell up to $6.4 millions shares under a sales agreement."
datetime: "2026-05-04T12:44:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285084724.md)
  - [en](https://longbridge.com/en/news/285084724.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285084724.md)
---

# 

22nd Century Group shares are trading lower after the company annoucned it filed a prospectus to sell up to $6.4 millions shares under a sales agreement.

### Related Stocks

- [XXII.US](https://longbridge.com/en/quote/XXII.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)

## Related News & Research

- [AbbVie Inc. $ABBV Shares Purchased by RiverFront Investment Group LLC](https://longbridge.com/en/news/286750290.md)
- [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)
- [ImmunityBio Expands Bladder Cancer Arsenal With Exclusive Japanese BCG Partnership](https://longbridge.com/en/news/286787574.md)
- [Wave Life Sciences posts positive RestorAATion-2 data; WVE-006 restores M-AAT, cuts Z-AAT, supports monthly dosing](https://longbridge.com/en/news/286818220.md)
- [Bayer Granted Priority Review For Asundexian In Secondary Stroke Prevention](https://longbridge.com/en/news/286884841.md)